Please login to the form below

Not currently logged in

Another IO knockback as Tecentriq combo fails phase III trial

Roche Basel Switzerland

The bulk of CRC patients with MSS currently look set to be excluded from cancer immunotherapy

Daily Brief

A rapid round-up of the top pharma, biotech and healthcare news

Daily Brief: Deal done, Takeda to cut $1.4bn, Brexit latest, Valeant rebrands

Takeda pharma buildingA rapid round-up of the top pharma, biotech and healthcare news

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

Gene therapyA rapid round-up of pharma, biotech and healthcare news

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more

BiosimilarsA rapid run-down of news in pharma, biotech and healthcare

The shifting healthcare landscape

Featured jobs

Subscribe to our email news alerts


Add my company

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....